Author details

Full Name

Olga Potapova

Affiliation

ORCID

Career Start Year

1996

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
31944652	Small-Molecule Antagonists of the RIG-I Innate Immune Receptor.	ACS Chem Biol	2020
32259542	Sequencing and Structure Probing of Long RNAs Using MarathonRT: A Next-Generation Reverse Transcriptase.	J Mol Biol	2020
31408339	Discovery of <i>N</i>-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and II.	J Med Chem	2019
29492454	A minimal RNA ligand for potent RIG-I activation in living mice.	Sci Adv	2018
28180316	Selective RNA targeting and regulated signaling by RIG-I is controlled by coordination of RNA and ATP binding.	Nucleic Acids Res	2017
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
24173222	Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.	J Virol	2014
25414026	Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.	Breast Cancer Research and Treatment	2014
23296054	The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients.	Gene	2013
23831915	Conformational landscapes of DNA polymerase I and mutator derivatives establish fidelity checkpoints for nucleotide insertion.	Nature Communications	2013
22206048	Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers.	American Journal of Cancer Research (discontinued)	2012
21826252	Biospecimen Reporting for Improved Study Quality.	Biopreserv Biobank	2011
22593799	Exploring molecular pathways of triple-negative breast cancer.	Genes and Cancer	2011
21433001	Biospecimen reporting for improved study quality (BRISQ).	Cancer Cytopathol	2011
22008035	Kinetic analysis of the unique error signature of human DNA polymerase Î½.	Biochemistry	2011
21574648	Biospecimen reporting for improved study quality (BRISQ).	J Proteome Res	2011
21809674	[Significant regression of glioblastoma with low level of Mgmt gene expression following radiotherapy].	Voprosy Onkologii	2011
20080740	Conformational transitions in DNA polymerase I revealed by single-molecule FRET.	Proceedings of the National Academy of Sciences of the United States of America	2010
18473481	Fingers-closing and other rapid conformational changes in DNA polymerase I (Klenow fragment) and their role in nucleotide selectivity.	Biochemistry	2008
16831866	The properties of steric gate mutants reveal different constraints within the active sites of Y-family and A-family DNA polymerases.	Journal of Biological Chemistry	2006
16411765	DNA polymerase catalysis in the absence of Watson-Crick hydrogen bonds: analysis by single-turnover kinetics.	Biochemistry	2006
16731761	Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248.	Molecular Cancer Therapeutics	2006
12773623	The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells.	Proceedings of the National Academy of Sciences of the United States of America	2003
14562043	Role of the RNA-binding protein HuR in colon carcinogenesis.	Oncogene	2003
12023283	The mutational specificity of the Dbh lesion bypass polymerase and its implications.	Journal of Biological Chemistry	2002
11900537	3'-5' exonuclease of Klenow fragment: role of amino acid residues within the single-stranded DNA binding region in exonucleolysis and duplex DNA melting.	Biochemistry	2002
12388775	Na pump isoforms in human erythroid progenitor cells and mature erythrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2002
12036942	Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression.	Cancer Res	2002
11283254	Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.	Mol Cell Biol	2001
11352915	Protective role for c-Jun in the cellular response to DNA damage.	Journal of Biological Chemistry	2001
11349126	Contacts between the 5' nuclease of DNA polymerase I and its DNA substrate.	Journal of Biological Chemistry	2001
11333986	Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.	Nature	2001
10669748	Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner.	Mol Cell Biol	2000
10825181	c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells.	J Biol Chem	2000
10565024	Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family.	Methods in Enzymology	2000
10022881	The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.	Molecular and Cellular Biology	1999
9162025	The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.	Journal of Biological Chemistry	1997
8542581	Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.	Cancer Research	1996
8647631	Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.	International Journal of Cancer	1996